{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:41:43Z","timestamp":1790116903619,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12072-015-9641-1","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T05:56:51Z","timestamp":1435903011000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sepsis-induced acute kidney injury in patients with cirrhosis"],"prefix":"10.1007","volume":"10","author":[{"given":"Paolo","family":"Angeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pilutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Morando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"issue":"Suppl 1","key":"9641_CR1","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","volume":"48","author":"P Angeli","year":"2008","unstructured":"Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol 2008;48(Suppl 1):S93\u2013S103","journal-title":"J Hepatol"},{"key":"9641_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164\u2013176","journal-title":"Hepatology"},{"key":"9641_CR3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arteriolar vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151\u20131157","journal-title":"Hepatology"},{"key":"9641_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz del Arbol","year":"2005","unstructured":"Ruiz del Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, et al. Circulatory function and hepato-renal syndrome. Hepatology 2005;42:439\u2013447","journal-title":"Hepatology"},{"key":"9641_CR5","doi-asserted-by":"crossref","unstructured":"Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015;64:531\u2013537","DOI":"10.1136\/gutjnl-2014-308874"},{"key":"9641_CR6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495\u20131501","journal-title":"Hepatology"},{"key":"9641_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S Fasolato","year":"2007","unstructured":"Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007;45:223\u2013229","journal-title":"Hepatology"},{"key":"9641_CR8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gin\u00e8s P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1426\u20131437","journal-title":"Gastroenterology"},{"key":"9641_CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.12559","volume":"35","author":"G Mehta","year":"2015","unstructured":"Mehta G, Mookerjee RP, Sharma V, Jalan R. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure. Liver Int 2015;35:724\u2013734","journal-title":"Liver Int"},{"key":"9641_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840180520","volume":"18","author":"C Guarner","year":"1993","unstructured":"Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139\u20131143","journal-title":"Hepatology"},{"key":"9641_CR11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/jhep.2003.50304","volume":"38","author":"D las Heras De","year":"2003","unstructured":"De las Heras D, Fern\u00e1ndez J, Gin\u00e8s P, C\u00e1rdenas A, Ortega R, Navasa M, et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 2003;38:452\u2013459","journal-title":"Hepatology"},{"key":"9641_CR12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz del Arbol","year":"2003","unstructured":"Ruiz del Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal and hepatic haemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210\u20131218","journal-title":"Hepatology"},{"key":"9641_CR13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(00)70180-6","volume":"118","author":"H Liu","year":"2000","unstructured":"Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 2000;118:937\u2013944","journal-title":"Gastroenterology"},{"key":"9641_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","volume":"51","author":"A Nazar","year":"2010","unstructured":"Nazar A, Pereira GH, Guevara M, Mart\u00edn-Llahi M, Pepin MN, Marinelli M, et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2010;51:219\u2013226","journal-title":"Hepatology"},{"key":"9641_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009;3:269\u2013282","journal-title":"Hepatol Int"},{"key":"9641_CR16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","volume":"60","author":"E Rodr\u00edguez","year":"2014","unstructured":"Rodr\u00edguez E, Elia C, Sol\u00e0 E, Barreto R, Graupera I, Andrealli A, et al. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. J Hepatol 2014;60:955\u2013961","journal-title":"J Hepatol"},{"key":"9641_CR17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","volume":"33","author":"N Shah","year":"2013","unstructured":"Shah N, Mohamed FE, Jover-Cobos M, Macnaughtan J, Davies N, Moreau R, et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int 2013;33:398\u2013409","journal-title":"Liver Int"},{"key":"9641_CR18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","volume":"56","author":"N Shah","year":"2012","unstructured":"Shah N, Dhar D, El Zahraa Mohammed F, Habtesion A, Davies NA, Jover-Cobos M, et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol 2012;56:1047\u20131053","journal-title":"J Hepatol"},{"key":"9641_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","volume":"41","author":"H Gomez","year":"2014","unstructured":"Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014;41:3\u201311","journal-title":"Shock"},{"key":"9641_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","volume":"57","author":"C Fagundes","year":"2012","unstructured":"Fagundes C, P\u00e9pin MN, Guevara M, Barreto R, Casals G, Sol\u00e0 E, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol 2012;57:267\u2013273","journal-title":"J Hepatol"},{"key":"9641_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","volume":"61","author":"R Barreto","year":"2014","unstructured":"Barreto R, Elia C, Sol\u00e0 E, Moreira R, Ariza X, Rodr\u00edguez E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. J Hepatol 2014;61:35\u201342","journal-title":"J Hepatol"},{"key":"9641_CR22","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","volume":"145","author":"F Wong","year":"2013","unstructured":"Wong F, O\u2019Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 2013;145:1280\u20131288","journal-title":"Gastroenterology"},{"key":"9641_CR23","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007;56:1310\u20131318","journal-title":"Gut"},{"key":"9641_CR24","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","volume":"59","author":"R Barreto","year":"2014","unstructured":"Barreto R, Fagundes C, Guevara M, Sol\u00e0 E, Pereira G, Rodr\u00edguez E, et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology 2014;59:1505\u20131513","journal-title":"Hepatology"},{"key":"9641_CR25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","volume":"140","author":"M Mart\u00edn-Llah\u00ed","year":"2011","unstructured":"Mart\u00edn-Llah\u00ed M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011;140:488\u2013496","journal-title":"Gastroenterology"},{"key":"9641_CR26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","volume":"30","author":"JM Trawal\u00e9","year":"2010","unstructured":"Trawal\u00e9 JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sall\u00e9e M, et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010;30:725\u2013732","journal-title":"Liver Int"},{"key":"9641_CR27","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","volume":"46","author":"D Thabut","year":"2007","unstructured":"Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007;46:1872\u20131882","journal-title":"Hepatology"},{"key":"9641_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403\u2013409","journal-title":"N Engl J Med"},{"key":"9641_CR29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","volume":"57","author":"M Guevara","year":"2012","unstructured":"Guevara M, Terra C, Nazar A, Sol\u00e0 E, Fern\u00e1ndez J, Pavesi M, et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol 2012;57:759\u2013765","journal-title":"J Hepatol"},{"key":"9641_CR30","author":"T Th\u00e9venot","year":"2014","unstructured":"Th\u00e9venot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol 2014;62:822\u2013830. doi: 10.1016\/j.jhep.2014.11.017","journal-title":"J Hepatol"},{"key":"9641_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","volume":"42","author":"J Fern\u00e1ndez","year":"2005","unstructured":"Fern\u00e1ndez J, Monteagudo J, Bargallo X, Jim\u00e9nez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 2005;42:627\u2013634","journal-title":"Hepatology"},{"key":"9641_CR32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","volume":"57","author":"A Bortoluzzi","year":"2013","unstructured":"Bortoluzzi A, Ceolotto G, Gola E, Sticca A, Bova S, Morando F, et al. Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology 2013;57:266\u2013276","journal-title":"Hepatology"},{"key":"9641_CR33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007;133:818\u2013824","journal-title":"Gastroenterology"},{"key":"9641_CR34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. A randomized prospective double blind, placebo controlled study of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008;134:1360\u20131368","journal-title":"Gastroenterology"},{"key":"9641_CR35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Martin-Llahi","year":"2008","unstructured":"Martin-Llahi M, Pepin MN, Guevara M, D\u00edaz F, Torre A, Monescillo A, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008;134:1352\u20131359","journal-title":"Gastroenterology"},{"key":"9641_CR36","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"P Angeli","year":"1999","unstructured":"Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999;29:1690\u20131697","journal-title":"Hepatology"},{"key":"9641_CR37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","volume":"56","author":"V Singh","year":"2012","unstructured":"Singh V, Ghosh S, Singh B, Kumar P, Sharma N, Bhalla A, et al. Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol 2012;56:1293\u20131298","journal-title":"J Hepatol"},{"key":"9641_CR38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/jhep.2002.36501","volume":"36","author":"R Moreau","year":"2002","unstructured":"Moreau R, Barri\u00e8re E, Tazi KA, Lardeux B, Darg\u00e8re D, Urbanowicz W, et al. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 2002;36:1070\u20131078","journal-title":"Hepatology"},{"key":"9641_CR39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","volume":"52","author":"E Esrailian","year":"2007","unstructured":"Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci 2007;52:742\u2013748","journal-title":"Dig Dis Sci"},{"key":"9641_CR40","doi-asserted-by":"crossref","unstructured":"Cavallin M, Kamath PS, Merli M, Fasolato S, Toniutto P, Salerno F et al. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. Hepatology 2015. doi: 10.1002\/hep.27709","DOI":"10.1002\/hep.27709"},{"issue":"(Sn2)","key":"9641_CR41","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/S0168-8278(15)30102-1","volume":"62","author":"F Wong","year":"2015","unstructured":"Wong F, Pappas SC, Boyer TD, Danyal AJ, Jamil K. Systemic inflammatory response syndrome (SIRS) is a major determinant of treatment response to terlipressin fro Hepatorenal Syndrome Type 1 (HRS-1). J Hepatol 2015;62(Sn2):S235\u2013S236","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9641-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9641-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9641-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:37:19Z","timestamp":1559432239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9641-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["9641"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9641-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]}}}